Home › Research › Disease mechanisms
Mice with pR927Q and pI712M Erbb4 Mutations Develop Features of Frontotemporal Dementia and ALS
Demetri D. Spyropoulos, Dorea P. Jenkins, Steven Lewis Carroll. Alzheimer s & Dementia, 2025-12-01
Topic: Brain proteins, microglia and lab models
Barnes Maze Acquisition was performed on males (N = 4-5/genotype) after habituation and several days training. Heatmaps of grouped averages for acquisition day 5 show that ErbB4-R927Q mutants (homozygotes > heterozygotes) take longer finding the goal box, suggesting a gene dosage-dependent defect in spatial learning. CatWalk-XT was performed on Erbb4-R927Q mutant females (N = 4-6/genotype), with six complaint post-training walks/animal. Significantly lower mean intensities of the most intense paw prints occurred in the hindlimbs of mutants (Tukey's 2-way ANOVA). Multiple gene-dosage-dependent trends in altered gait metrics occurred, including footfall patterns, 2D/3D mean/max intensities, footfall sequence, print positions, standing and diagonal mean phase dispersions. DXA scans on Erbb4-R927Q mutant and wild-type males (N = 5-9 per genotype) showed decreased body weights and fat percentages in homozygotes. Whole body and limb regions of interest showed decreases in bone mineral density and content that was greater in homozygotes than in heterozygotes. Initial findings suggest gene dosage-dependent abnormalities in Erbb4-R927Q mutants that have features of FTLD and ALS. A wider battery of tests on more animals, at different ages and including the Erbb4-I712M mutants are underway. Neuropathology is being assessed following consensus recommendations for FTLD and ALS. Stereology/morphometry and other methods will assess loss of ErbB4-expressing inhibitory interneurons and synaptic loss and how this evolves temporally.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Spyropoulos, D. D., Jenkins, D. P., & Carroll, S. L. (2025). Mice with pR927Q and pI712M Erbb4 Mutations Develop Features of Frontotemporal Dementia and ALS. Alzheimer s & Dementia. https://doi.org/10.1002/alz70855_106736
Vancouver
Spyropoulos DD, Jenkins DP, Carroll SL. Mice with pR927Q and pI712M Erbb4 Mutations Develop Features of Frontotemporal Dementia and ALS. Alzheimer s & Dementia. 2025. doi:10.1002/alz70855_106736. PMID: 41445252.
BibTeX
@article{spyropoulos2025-41445252,
author = {Spyropoulos, Demetri D. and Jenkins, Dorea P. and Carroll, Steven Lewis},
title = {{Mice with pR927Q and pI712M Erbb4 Mutations Develop Features of Frontotemporal Dementia and ALS}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz70855_106736},
pmid = {41445252},
url = {https://doi.org/10.1002/alz70855_106736}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Barnes Maze Acquisition was performed on males (N = 4-5/genotype) after habituation and several days training.
- Heatmaps of grouped averages for acquisition day 5 show that ErbB4-R927Q mutants (homozygotes > heterozygotes) take longer finding the goal box, suggesting a gene dosage-dependent defect in spatial learning.
- CatWalk-XT was performed on Erbb4-R927Q mutant females (N = 4-6/genotype), with six complaint post-training walks/animal.
- Significantly lower mean intensities of the most intense paw prints occurred in the hindlimbs of mutants (Tukey's 2-way ANOVA).
- Multiple gene-dosage-dependent trends in altered gait metrics occurred, including footfall patterns, 2D/3D mean/max intensities, footfall sequence, print positions, standing and diagonal mean phase dispersions.
Why it matters
Mice carrying Erbb4 mutations showed gene dosage-dependent problems with spatial learning, gait, body weight, and bone density that resemble features of frontotemporal dementia and ALS. These are early findings in small numbers of animals, and more testing is underway, so no treatment or prevention is established.
Study details
- Evidence strengthLow
How this study scored 33/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported and randomised / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Laboratory or animal study (title names “mice”) — scores zero |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Steven Lewis Carroll: h-index 48 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Medical University of South Carolina: institution h-index 715 (OpenAlex) |
| Multi-centre collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41445252) |
| Free to read | 2 / 2 | Free to read |
| Total | 33 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/alz70855_106736
- PubMed: 41445252
- Original source →
- Free full text: Alzheimer s & Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related studies in Disease mechanisms
Also tagged “mice”
1,150 studies in the library carry the topic tag “mice”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.